66 related articles for article (PubMed ID: 29951903)
1. Perceptions of Cancer Status Disclosure in Lebanon.
Temraz S; Salim Hammoud M; Saleh A; Charafeddine M; Mukherji D; Shamseddine A
J Cancer Educ; 2019 Oct; 34(5):874-881. PubMed ID: 29951903
[TBL] [Abstract][Full Text] [Related]
2. Parent and oncologist perspectives on prognostic disclosure in advanced childhood cancer: communication pearls and pitfalls.
Zalud K; Collins G; Baker JN; Mack JW; Kaye EC
Support Care Cancer; 2024 May; 32(6):341. PubMed ID: 38735892
[TBL] [Abstract][Full Text] [Related]
3. Unrealistic expectations and disclosure of incurability in patients with non-small cell lung cancer.
Hasegawa T; Okuyama T; Uemura T; Matsuda Y; Otani H; Shimizu J; Horio Y; Watanabe N; Yamaguchi T; Fukuda S; Oguri T; Maeno K; Inagaki Y; Nosaki K; Fukumitsu K; Akechi T
Support Care Cancer; 2024 Jun; 32(7):421. PubMed ID: 38856947
[TBL] [Abstract][Full Text] [Related]
4. Physician, patient and family attitudes regarding information on prognosis: a Brazilian survey.
Fumis RRL; De Camargo B; Del Giglio A
Ann Oncol; 2012 Jan; 23(1):205-211. PubMed ID: 21447619
[TBL] [Abstract][Full Text] [Related]
5. Effects of Prognostic Communication Strategies on Prognostic Perceptions, Treatment Decisions and End-Of-Life Anticipation in Advanced Cancer: An Experimental Study among Analogue Patients.
van der Velden NCA; Smets EMA; van Vliet LM; Brom L; van Laarhoven HWM; Henselmans I
J Pain Symptom Manage; 2024 Jun; 67(6):478-489.e13. PubMed ID: 38428696
[TBL] [Abstract][Full Text] [Related]
6. Challenges of mediated communication, disclosure and patient autonomy in cross-cultural cancer care.
Kai J; Beavan J; Faull C
Br J Cancer; 2011 Sep; 105(7):918-24. PubMed ID: 21863029
[TBL] [Abstract][Full Text] [Related]
7. How hereditary cancer risk disclosure to relatives is handled in practice - Patient perspectives from a Swedish cancer genetics clinic.
Hawranek C; Rosén A; Hajdarevic S
Patient Educ Couns; 2024 Sep; 126():108319. PubMed ID: 38788311
[TBL] [Abstract][Full Text] [Related]
8. Oncologists' Perceptions of Strategies for Discussing the Cost of Care with Cancer Patients and the Meaning of Those Conversations.
Scott AM; Harrington NG; Herman AA
Health Commun; 2024 Jun; 39(7):1343-1357. PubMed ID: 37190672
[TBL] [Abstract][Full Text] [Related]
9. How can communication by oncologists enhance patients' trust? An experimental study.
Hillen MA; de Haes HCJM; Stalpers LJA; Klinkenbijl JHG; Eddes EH; Butow PN; van der Vloodt J; van Laarhoven HWM; Smets EMA
Ann Oncol; 2014 Apr; 25(4):896-901. PubMed ID: 24615411
[TBL] [Abstract][Full Text] [Related]
10. Oncologists' experience with discussing cancer prognosis with patients and families: perspectives from India.
Maya S; Banerjee SC; Chawak S; Parker PA; Kandikattu S; Chittem M
Transl Behav Med; 2021 Oct; 11(10):1896-1904. PubMed ID: 34170321
[TBL] [Abstract][Full Text] [Related]
11. Patients' and oncologists' perceptions towards the discussion on high-cost innovative cancer therapies: findings from a qualitative study.
Bashkin O; Dopelt K; Asna N
BMJ Open; 2022 Sep; 12(9):e062104. PubMed ID: 36167390
[TBL] [Abstract][Full Text] [Related]
12. Patients' and family members' views on how clinicians enact and how they should enact incident disclosure: the "100 patient stories" qualitative study.
Iedema R; Allen S; Britton K; Piper D; Baker A; Grbich C; Allan A; Jones L; Tuckett A; Williams A; Manias E; Gallagher TH
BMJ; 2011 Jul; 343():d4423. PubMed ID: 21788260
[TBL] [Abstract][Full Text] [Related]
13. Revealing a cancer diagnosis to patients: attitudes of patients, families, friends, nurses, and physicians in Lebanon-results of a cross-sectional study.
Farhat F; Othman A; El Baba G; Kattan J
Curr Oncol; 2015 Aug; 22(4):e264-72. PubMed ID: 26300677
[TBL] [Abstract][Full Text] [Related]
14. Representing randomness in the communication of individualized cancer risk estimates: effects on cancer risk perceptions, worry, and subjective uncertainty about risk.
Han PK; Klein WM; Killam B; Lehman T; Massett H; Freedman AN
Patient Educ Couns; 2012 Jan; 86(1):106-13. PubMed ID: 21377311
[TBL] [Abstract][Full Text] [Related]
15. Reminder in scarlet: balancing empathy and detachment in oncology.
Krishnamurthy R
Indian J Med Ethics; 2024; IX(2):159-160. PubMed ID: 38755774
[TBL] [Abstract][Full Text] [Related]
16. Support Seeking or Familial Obligation: An Investigation of Motives for Disclosing Genetic Test Results.
Greenberg M; Smith RA
Health Commun; 2016; 31(6):668-78. PubMed ID: 26507777
[TBL] [Abstract][Full Text] [Related]
17. A family genetic risk communication framework: guiding tool development in genetics health services.
Wiens ME; Wilson BJ; Honeywell C; Etchegary H
J Community Genet; 2013 Apr; 4(2):233-42. PubMed ID: 23319393
[TBL] [Abstract][Full Text] [Related]
18. Clinicians' routine use of non-disclosure: prioritizing "protection" over the information needs of adolescents with cancer.
Clemente I
Can J Nurs Res; 2007 Dec; 39(4):19-34. PubMed ID: 18277786
[TBL] [Abstract][Full Text] [Related]
19. Nutrition in patients with cancer: a new area for medical oncologists? A practising oncologist's interdisciplinary position paper.
Rauh S; Antonuzzo A; Bossi P; Eckert R; Fallon M; Fröbe A; Gonella S; Giusti R; Lakatos G; Santini D; Villarini A
ESMO Open; 2018; 3(4):e000345. PubMed ID: 29765772
[No Abstract] [Full Text] [Related]
20. Epidemiology of Ocular Malignancies Among the Lebanese Population: A 12-Year Review.
Akiki D; El Hage S; El Masri J; Chanbour W
Cureus; 2022 Jan; 14(1):e21593. PubMed ID: 35228951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
